KMG Fiduciary Partners LLC trimmed its stake in Oracle Co. (NYSE:ORCL - Free Report) by 10.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 71,908 shares of the enterprise software provider's stock after selling 8,495 shares during the period. Oracle accounts for about 0.8% of KMG Fiduciary Partners LLC's investment portfolio, making the stock its 29th biggest holding. KMG Fiduciary Partners LLC's holdings in Oracle were worth $10,053,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also recently modified their holdings of the stock. Norges Bank bought a new stake in Oracle during the 4th quarter valued at about $2,216,314,000. Raymond James Financial Inc. bought a new stake in Oracle during the 4th quarter valued at about $930,095,000. GAMMA Investing LLC increased its stake in Oracle by 15,012.3% during the 1st quarter. GAMMA Investing LLC now owns 4,755,096 shares of the enterprise software provider's stock valued at $664,810,000 after purchasing an additional 4,723,631 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its stake in Oracle by 20.5% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 13,825,360 shares of the enterprise software provider's stock valued at $2,303,858,000 after purchasing an additional 2,350,448 shares in the last quarter. Finally, Vanguard Group Inc. increased its stake in Oracle by 1.5% during the 4th quarter. Vanguard Group Inc. now owns 157,411,949 shares of the enterprise software provider's stock valued at $26,231,127,000 after purchasing an additional 2,296,069 shares in the last quarter. 42.44% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
ORCL has been the subject of a number of analyst reports. Evercore ISI reduced their price objective on shares of Oracle from $200.00 to $185.00 and set an "outperform" rating for the company in a research note on Tuesday, March 11th. Stephens started coverage on shares of Oracle in a research note on Wednesday, March 19th. They set an "equal weight" rating and a $167.00 price objective for the company. JPMorgan Chase & Co. reduced their price target on shares of Oracle from $140.00 to $135.00 and set a "neutral" rating for the company in a research note on Tuesday, March 11th. Loop Capital set a $135.00 price target on shares of Oracle in a research note on Tuesday. Finally, Barclays reduced their price target on shares of Oracle from $212.00 to $202.00 and set an "overweight" rating for the company in a research note on Tuesday, March 11th. Twelve equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Oracle presently has a consensus rating of "Moderate Buy" and a consensus price target of $175.78.
Read Our Latest Report on ORCL
Oracle Price Performance
Shares of ORCL stock traded down $1.15 on Wednesday, hitting $176.33. 15,806,498 shares of the stock traded hands, compared to its average volume of 10,755,257. The firm has a market cap of $493.20 billion, a price-to-earnings ratio of 43.11, a PEG ratio of 3.46 and a beta of 1.32. Oracle Co. has a 52 week low of $118.86 and a 52 week high of $198.31. The firm has a 50 day simple moving average of $148.64 and a two-hundred day simple moving average of $160.25. The company has a debt-to-equity ratio of 5.65, a current ratio of 0.81 and a quick ratio of 0.81.
Oracle (NYSE:ORCL - Get Free Report) last announced its quarterly earnings data on Monday, March 10th. The enterprise software provider reported $1.47 EPS for the quarter, missing the consensus estimate of $1.49 by ($0.02). The firm had revenue of $14.13 billion for the quarter, compared to the consensus estimate of $14.40 billion. Oracle had a net margin of 21.16% and a return on equity of 133.25%. The firm's revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.41 earnings per share. As a group, equities research analysts predict that Oracle Co. will post 5 earnings per share for the current fiscal year.
Insider Buying and Selling
In other Oracle news, Director Naomi O. Seligman sold 2,866 shares of the stock in a transaction on Monday, May 5th. The shares were sold at an average price of $149.53, for a total transaction of $428,552.98. Following the completion of the transaction, the director now owns 31,764 shares in the company, valued at $4,749,670.92. This trade represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Leon E. Panetta sold 5,000 shares of the stock in a transaction on Friday, April 11th. The shares were sold at an average price of $129.77, for a total transaction of $648,850.00. Following the transaction, the director now owns 58,090 shares of the company's stock, valued at $7,538,339.30. This trade represents a 7.93% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 27,366 shares of company stock worth $4,015,723. 42.20% of the stock is owned by insiders.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Featured Stories

Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report